blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1984351

EP1984351 - COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.01.2013
Database last updated on 13.11.2024
Most recent event   Tooltip25.01.2013Application deemed to be withdrawnpublished on 27.02.2013  [2013/09]
Applicant(s)For all designated states
Memory Pharmaceuticals Corporation
100 Philips Parkway
Montvale, NJ 07645 / US
[2008/44]
Inventor(s)01 / DUNN, Robert
3 Osborne Place
Towaco, NJ 07082 / US
02 / NGUYEN, Truc, Minh
1732 46th.Street
Des Moines, 50310 Iowa / US
03 / XIE, Wenge
2347 Pembroke Court
Mahwah, NJ 07430 / US
04 / TEHIM, Ashok
246 N Walnut St
Ridgewood, NJ 07450 / US
 [2008/51]
Former [2008/44]01 / DUNN, Robert
3 Osborne Place
Towaco, NJ 07082 / US
02 / NGUYEN, Truc, Minh
3 East 101 St Apt 5e
New York, NY 10029 / US
03 / XIE, Wenge
2347 Pembroke Court
Mahwah, NJ 07430 / US
04 / TEHIM, Ashok
246 N Walnut St
Ridgewood, NJ 07450 / US
Representative(s)Pistolesi, Roberto, et al
Dragotti & Associati Srl
Via Nino Bixio, 7
20129 Milano / IT
[N/P]
Former [2008/44]Pistolesi, Roberto, et al
Dragotti & Associati srl Via Marina 6
20121 Milano / IT
Application number, filing date07757140.416.02.2007
[2008/44]
WO2007US62340
Priority number, dateUS20060774399P17.02.2006         Original published format: US 774399 P
[2008/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007098418
Date:30.08.2007
Language:EN
[2007/35]
Type: A1 Application with search report 
No.:EP1984351
Date:29.10.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 30.08.2007 takes the place of the publication of the European patent application.
[2008/44]
Search report(s)International search report - published on:EP30.08.2007
ClassificationIPC:C07D401/04, C07D471/04, C07D417/14, C07D405/14, C07D403/14, A61K31/404, A61P25/00
[2008/44]
CPC:
C07D401/04 (EP,US); A61P1/04 (EP); A61P1/10 (EP);
A61P1/14 (EP); A61P25/00 (EP); A61P25/06 (EP);
A61P25/08 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/20 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P25/32 (EP);
A61P25/34 (EP); A61P25/36 (EP); A61P3/00 (EP);
A61P3/04 (EP); A61P31/12 (EP); A61P37/04 (EP);
A61P37/08 (EP); A61P39/02 (EP); A61P43/00 (EP);
A61P7/04 (EP); A61P9/00 (EP); A61P9/10 (EP);
C07D403/14 (EP,US); C07D405/14 (EP,US); C07D417/14 (EP,US);
C07D471/04 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/44]
Extension statesAL26.03.2008
BA26.03.2008
HR26.03.2008
MK26.03.2008
RS26.03.2008
TitleGerman:VERBINDUNGEN MIT 5-HT6-REZEPTOR-AFFINITÄT[2008/44]
English:COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY[2008/44]
French:COMPOSES AYANT UNE AFFINITE POUR LE RECEPTEUR 5-HT6[2008/44]
Entry into regional phase26.03.2008National basic fee paid 
26.03.2008Designation fee(s) paid 
26.03.2008Examination fee paid 
Examination procedure26.03.2008Amendment by applicant (claims and/or description)
26.03.2008Examination requested  [2008/44]
25.05.2012Despatch of a communication from the examining division (Time limit: M04)
01.09.2012Application deemed to be withdrawn, date of legal effect  [2013/09]
10.10.2012Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2013/09]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.05.2012
Fees paidRenewal fee
09.02.2009Renewal fee patent year 03
08.02.2010Renewal fee patent year 04
06.01.2011Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
29.02.201206   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9213856  (PFIZER [US]) [X] 1-62 * example - *;
 [Y]WO0063203  (ALLELIX BIOPHARMA [CA]) [Y] 1-62 * the whole document *;
 [Y]WO0112629  (NPS ALLELIX CORP [CA]) [Y] 1-62 * the whole document *;
 [Y]WO02051837  (WYETH CORP [US]) [Y] 1-62 * the whole document *;
 [YD]US6133287  (SLASSI ABDELMALIK [CA], et al) [YD] 1-62 * the whole document *;
 [YD]US6686374  (EDWARDS LOUISE [CA], et al) [YD] 1-62 * the whole document *
 [X]  - COLE D C ET AL, "N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (20050117), vol. 15, no. 2, ISSN 0960-894X, pages 379 - 383, XP004694276 [X] 1-62 * examples 15l,15y,15z *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2004.10.064
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.